CMS Not Willing To Expand Alzheimer's Drug Coverage
Drug Topics
MARCH 1, 2023
CMS has no plans to change their coverage and approval process, which the Alzheimer's Association believes is standing between patients and treatment.
Drug Topics
MARCH 1, 2023
CMS has no plans to change their coverage and approval process, which the Alzheimer's Association believes is standing between patients and treatment.
PhRMA
MARCH 1, 2023
The United States Patent and Trademark Office (USPTO) and the U.S. Food and Drug Administration (FDA) are in the process of considering new collaboration initiatives aimed at biopharmaceutical patents. As outlined in a recent public statement and written comments , PhRMA appreciates the agencies seeking public participation on important innovation policy issues and we strongly support the agencies stated commitment to “ensuring our innovation system strikes the appropriate balance—encouraging me
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
MARCH 1, 2023
How can technology help pharmacists manage inventory—and the associated costs?
PharmaVoice
MARCH 1, 2023
As chief people officer, Dunkle is harnessing the company’s unique culture to foster innovation.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
MARCH 1, 2023
The DEA is hoping to expand health care accessibility while also safeguarding from incorrectly prescribing medication.
Fierce Pharma
MARCH 1, 2023
Pfizer, Viatris and more must face 'overarching conspiracy' claims in generic price-fixing suit aliu Wed, 03/01/2023 - 10:03
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
PharmaVoice
MARCH 1, 2023
A BMJ study found that spending on drug sales vastly outstripped spending on drug development.
Fierce Healthcare
MARCH 1, 2023
Cleveland Clinic closes Q4 strong but ultimately logs $1.
Fierce Pharma
MARCH 1, 2023
Eli Lilly slashes insulin prices by 70%, caps out-of-pocket costs in major access overhaul fkansteiner Wed, 03/01/2023 - 08:40
Fierce Healthcare
MARCH 1, 2023
Bright Health staring down bankruptcy, needs to raise $300M, execs say pminemyer Wed, 03/01/2023 - 14:40
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
MARCH 1, 2023
Genome editing summits are generally friendly, nerdy affairs, but for a moment at a Lisbon hotel last June, the conversation at the FASEB genome engineering conference grew tense. Tessera Therapeutics chief scientist Michael Holmes had just finished presenting a much-anticipated peek at a technology the company had previously said could “ revolutionize genetic medicine ” and “cure nearly any genetic disease.
Fierce Healthcare
MARCH 1, 2023
Northwest Permanente P.C.
Drug Store News
MARCH 1, 2023
Target will begin enabling customers to make drive-up product returns at its stores this spring, with plans to offer the service at all of its stores by the end of summer.
Fierce Healthcare
MARCH 1, 2023
BCBSA: Broader site-neutral payment policies would save $471B over 10 years dmuoio Wed, 03/01/2023 - 14:20
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Drug Store News
MARCH 1, 2023
Ask Your Pharmacist was launched to bring attention and recognition to all of the services pharmacists offer their communities.
STAT
MARCH 1, 2023
It’s an author affiliation that would make even the most seasoned scientist do a double take: New research on artificial intelligence-powered protein design, written by researchers at, of all places, Salesforce. From Meta to TikTok’s parent company ByteDance, nearly every tech company has research programs on large language models, the foundational technology behind text-generating AI tools like ChatGPT.
Fierce Healthcare
MARCH 1, 2023
House oversight panel launches new probe into major PBM tactics rking Wed, 03/01/2023 - 15:09
STAT
MARCH 1, 2023
Eli Lilly, one of the largest makers of insulin, said Wednesday it would make dramatic cuts to the prices of several of its older insulin products in an effort to lower costs for consumers whose insulin is not fully paid for by insurance. It also expanded its program to cap out-of-pocket insulin costs at $35 for people who do have health insurance. The moves come amid a public and political uproar over the price of insulin.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Fierce Healthcare
MARCH 1, 2023
Privia Health nets $17.
STAT
MARCH 1, 2023
At the peak of the pandemic, essential workers faced rampant tech-based surveillance, from overhead infrared thermometers to wearables that tracked their proximity to one another. These technologies forced employees to adjust the way they worked and sometimes made their workplaces less safe. They also didn’t offer workers clear and accurate information that would help them protect their health, according to a new report by the nonprofit Data & Society.
BioPharm
MARCH 1, 2023
There is growing pressure for robust and economically scalable viral-vector manufacturing technologies.
Drug Store News
MARCH 1, 2023
The latest Sally Hansen Insta-Dri X Peeps collection comes in seven shades, including a sugar texture for a finish that mimics the feel of sugar-coated Peeps.
ISPE
MARCH 1, 2023
EU Gmp Annex 1 - Impact on Cleaning & Disinfection Trudy Patterson Wed, 03/01/2023 - 06:00 White Paper — Sponsored Content EU Gmp Annex 1 - Impact on Cleaning & Disinfection 1 March 2023 Cleaning and microbial contamination control are critical focus areas in pharmaceutical and medical device industries. Robust cleaning and disinfection programs are needed to meet the required cleanroom microbial grades, to prevent cross contamination and subsequent microbial contamination of products.
Drug Store News
MARCH 1, 2023
ImPress Press-On Falsies use a pre-bonded lash technology that eliminates the need for glue, the company said.
ISPE
MARCH 1, 2023
Water Needs in Pharma Quality Control Trudy Patterson Wed, 03/01/2023 - 06:38 White Paper — Sponsored Content Water Needs in Pharma Quality Control 1 March 2023 Water is one of the most widely used substances in the pharmaceutical industry. It functions as an ingredient, a cleaning agent, a reagent, a solvent and a product, throughout the drug discovery process, from the initial identification of potential drug targets, all the way to the manufacture and quality control of the final product.
Drug Store News
MARCH 1, 2023
Giant is celebrating National Nutrition Month in March with free, live classes via Zoom for families and chefs of all ages.
European Pharmaceutical Review
MARCH 1, 2023
A new £2.7 million collaboration between the Centre for Process Innovation (CPI), AstraZeneca, Novartis, and The University of Manchester aims to revolutionise oligonucleotide manufacture. The three-year project is planned to translate “…approaches to oligonucleotide synthesis into sustainable manufacturing processes. We are hopeful that this collaboration will… ensure the widest possible access to this emerging class of therapeutics,” shared Sarah Lovelock, Senior Lecturer at Manchester I
STAT
MARCH 1, 2023
The U.S. Department of Health and Human Services has for decades ignored its responsibility to enforce civil rights laws, as I argued last year in a First Opinion essay. Doing nothing to protect minority populations from inequitable health harms resulting from the health care industry’s greenhouse gas emissions constitutes environmental and institutional racism.
European Pharmaceutical Review
MARCH 1, 2023
Three-dimensional images using computed tomography (CT) provide a valuable, non‑invasive insight into the inner morphology of freeze-dried products. This technology allows the pore structure to be visualised in a similar way to scanning electron microscopy. It enables the detection and traceability of structural alterations and/or impurities as well as verification of the container closure integrity.
Drug Store News
MARCH 1, 2023
The new line includes tincture and soft gel products.
Pharmaceutical Technology
MARCH 1, 2023
The US Food and Drug Administration (FDA) has granted approval for Regeneron Pharmaceuticals and Sanofi ’s Kevzara (sarilumab) to treat polymyalgia rheumatica (PMR) in adult patients. Kevzara has been approved as the first and only biologic indicated for PMR adult patients who did not respond to corticosteroids or who cannot tolerate corticosteroid taper.
Drug Store News
MARCH 1, 2023
This annual award, overseen by NASPA and sponsored by Upsher-Smith, honors innovators in the pharmacy field.
Fierce Healthcare
MARCH 1, 2023
Precision medicine company Tempus inks 3rd major pharma deal, securing nearly $1B revenue boost hlandi Wed, 03/01/2023 - 11:32
Let's personalize your content